Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Selfcare

This article was originally published in The Gray Sheet

Executive Summary

Selfcare: Initial public offering of 1.3 mil. shares priced at $8.50 per share nets the firm $10.3 mil. An overallotment option of 195,000 shares is still outstanding. The Waltham, Massachusetts-based maker of "self-test" diagnostics for diabetes, women's health and infectious diseases plans to use the proceeds for R&D, working capital and "other general corporate purposes, including the possible repayment of certain indebtedness and possible acquisitions," the firm states. In a registration statement for the offering, filed with the Securities and Exchange Commission in May, Selfcare projected an offering of 2.7 mil. shares for $12 each ("The Gray Sheet" June 17, p. 26). The issue will trade on the American Stock Exchange under the symbol "SLF"...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006502

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel